Shares fall 19%. ([email protected]) 0612 ET – Merck KGaA should post higher 3Q earnings and sales, and investors will focus on the company’s prospects for its electronics division, which is boosted ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...